CVS Health Co. (NYSE:CVS) Shares Sold by Caprock Group LLC

Caprock Group LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 3.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,628 shares of the pharmacy operator’s stock after selling 1,194 shares during the period. Caprock Group LLC’s holdings in CVS Health were worth $2,303,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the third quarter worth about $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA increased its stake in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health during the 3rd quarter worth approximately $33,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on CVS shares. Truist Financial upped their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. Mizuho reduced their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Wells Fargo & Company upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $60.00 to $66.00 in a report on Monday. Finally, Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $72.78.

CVS Health Stock Down 0.4 %

CVS opened at $55.82 on Wednesday. The business has a 50 day moving average price of $59.18 and a two-hundred day moving average price of $58.60. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The company has a market cap of $70.24 billion, a PE ratio of 14.17, a P/E/G ratio of 0.92 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the company earned $2.21 earnings per share. As a group, research analysts anticipate that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.77%. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.